What Is a Term Sheet? The VC Analyst's Field Guide

A term sheet is a non-binding document that frames the economic and governance terms of a venture investment before the lawyers start drafting final agreements. For early-stage VC analysts, it is where the real negotiation happens, not in the stock purchase agreement that follows. What is a term sheet in practice? Seven sections, roughly ten to twelve pages, and the starting point of a relationship that will last eight to twelve years.

A term sheet is a negotiating framework, not a commitment

Two things are almost always binding: the confidentiality clause and the exclusivity window, typically 30 to 60 days during which the company agrees not to seek competing offers. Everything else is an opening position.

Term sheets arrive in two formats in practice. Some funds use the NVCA model documents as a starting point and modify from there. Others use proprietary templates that may omit standard clauses or reorder them in ways that require attention. Reading the structure before reading the numbers is a habit worth building early.

Founders who receive a first term sheet often focus on valuation and ownership percentage. Analysts working the deal from the fund side focus on three other things first: the liquidation preference structure, the board seat allocation, and the information rights. Those three clauses determine more of the deal's long-term character than the headline pre-money number.

This matters operationally. When a term sheet arrives, the analyst's job is not to celebrate; it is to read the structure, not the headline valuation. A 5M EUR investment at a 20M EUR pre-money valuation with a 2x participating liquidation preference is worth less to the founder than a 4M EUR investment at an 18M EUR pre-money with a 1x non-participating preference. The math matters more than the number on the cover page.

The seven sections every analyst reads in sequence

Standard VC term sheets follow a consistent architecture. Analysts who read them in order are faster and miss fewer flags.

Offering terms. Pre-money valuation, total round size, price per share, and the share class. This is also where the employee option pool size appears, which directly dilutes founders before the investment closes. A pool refresh from 10% to 15% on a 20M EUR pre-money round is not cosmetic.

Charter terms. The substantive section. Dividend policy, liquidation preference (multiple and participating vs. non-participating), anti-dilution protection, and pay-to-play provisions. Analysts spend more time here than anywhere else.

Stock purchase agreement. Representations and warranties, closing conditions, and regulatory compliance. In EU deals, data room access restrictions and GDPR representations appear here. They are not boilerplate.

Investor rights agreement. Information rights (monthly management accounts, quarterly financials, annual audited statements), board observer rights, and registration rights. This section governs ongoing access during the investment period.

Right of first refusal and co-sale. The investor's right to buy shares before a founder sells to a third party, and the right to participate in any secondary sale. Standard in European funds; occasionally waived in competitive rounds.

Voting agreement. Board composition, drag-along rights, and protective provisions. Protective provisions are the list of actions the company cannot take without investor approval: issuing new shares, selling the company, changing the board structure. In Q2 2025, more than 90% of venture rounds included protective provisions as standard.

Other terms. Expiration date, no-shop clause, legal fees allocation (the investor's counsel is paid by the company, typically capped at EUR 15,000 to EUR 25,000 in European deals), and counsel selection.

Liquidation preference: why the structure matters more than the multiple

The liquidation preference determines who gets paid first, and how much, when the company is sold or dissolved. It is the clause that transfers value most invisibly between founders and investors.

In Q2 2025, 98% of venture rounds reverted to a 1x non-participating liquidation preference. This means the investor receives either their original investment or their pro-rata share of the proceeds, whichever is greater, but not both.

The alternative, a participating preferred structure, lets the investor take their preference first and then participate in the remaining proceeds alongside common stockholders. Consider a 30M EUR exit for a company that raised 5M EUR at a 15M EUR pre-money valuation. The difference between a 1x non-participating and a 1x participating preference can reach 1.5M EUR to 2M EUR in founder proceeds.

For small EU funds managing 50M EUR to 150M EUR, the liquidation preference discussion surfaces at seed stage in ways that US funds left behind after 2021. Analysts should treat participating structures in early-stage deals as signals of structural asymmetry rather than standard practice.

Multiples above 1x, whether 1.5x or 2x preferences, are rare in current conditions but appear more frequently in bridge rounds with uncertain paths to a priced round. Flag them clearly in the IC memo.

Anti-dilution and pro-rata rights: what they signal about investor confidence

Anti-dilution provisions protect investors when the company raises subsequent rounds at a lower valuation, a down round. The two structures are full ratchet and weighted average.

Full ratchet is aggressive: the conversion price of the investor's preferred shares adjusts down to match the new lower price, regardless of how many new shares are issued. It severely penalizes founders and employees in down rounds. Most EU early-stage deals use broad-based weighted average anti-dilution instead, which factors in the size of the new financing and adjusts proportionally.

Pro-rata rights give investors the option to maintain their percentage ownership in future rounds by investing their proportional share. A 2M EUR investor holding 15% of a company has the right to invest 15% of the Series B round to keep their stake flat. This clause matters more than it appears on first read: in power-law returns, the ability to maintain ownership in outliers determines fund performance.

When an investor negotiates a right to more than their pro-rata share, a super pro-rata right, it signals high conviction but also raises governance questions about round concentration.

The presence or absence of pro-rata rights in a seed term sheet is a useful signal. An investor who does not ask for them either does not expect the company to raise again or is not in a position to follow on. Both scenarios matter for the Monday morning shortlist.

EU term sheets versus US term sheets: three structural differences

European early-stage term sheets follow the same framework as US models but differ in three ways that matter operationally.

Data room and GDPR clauses. EU deals regularly include representations about the company's GDPR compliance posture and restrictions on where due diligence materials may be stored. This is not cosmetic: a US fund holding personal data of EU founders in a US-based data room is making an implicit legal choice.

Preferred versus convertible structures. SAFE notes and simple convertible instruments, standard at US seed stage, are used less frequently in European deals. Many EU seed rounds close on equity term sheets with priced preferred shares. This affects cap table complexity and investor rights earlier in the company lifecycle.

Exit provisions and drag-along thresholds. European venture investors often negotiate lower drag-along thresholds, sometimes 50% of preferred rather than a supermajority, because exit liquidity windows in EU markets have historically been narrower and more time-constrained. The drag-along clause specifies when investors can compel all shareholders, including founders, to accept an acquisition offer.

How AI-assisted review changes what analysts flag in a term sheet

Most funds under 200M EUR still review term sheets manually, meaning every clause comparison against market standard happens by memory or by opening a reference term sheet from a prior deal. For a 3-person fund that closes 8 to 12 deals per year, a structured term sheet database is often a Notion page rather than a purpose-built tool. That works until it does not: when a founder's counsel inserts a non-standard clause and no one on the fund's side catches it before countersigning.

AI-assisted deal intelligence tools now change this for analysts who use them. The practical use case is not automatic term sheet parsing but reference comparison: how does the liquidation preference in this term sheet compare to the last 20 deals the fund has reviewed in the same stage and sector?

Coverage before conviction is a useful frame here. An analyst who has reviewed 200 term sheets in a given vertical knows what a standard clause looks like. An analyst on deal number 12 does not. AI-assisted sourcing and deal data tools give access to that comparative context earlier in the process, without the overhead of building a manual database.

The IC memo does not write itself, but it can get a first draft when the term sheet review is structured and the flags are documented. Less typing, more thinking.

What to check before signing the exclusivity window

Once exclusivity starts, the fund's negotiating position weakens. The analyst's job before that clock starts is to verify four things: that the pre-money valuation is stated unambiguously; that the liquidation preference multiple and structure match what was discussed verbally; that the board composition post-close gives the fund the representation it expects; and that the information rights are specific enough to enforce.

Vague information rights clauses are a flag. Standard language specifies monthly unaudited management accounts within 15 days of month-end, quarterly reports within 30 days, and audited annual financials within 90 days. If those timelines are not in the term sheet, they will not be in the shareholder agreement either.

The no-shop clause is binding from signature. What happens during the exclusivity window determines the quality of the final investment agreement. Treat the term sheet review as a working document, not a formality. The IC memo will be cleaner for it.

If a term sheet is underspecified on any of the four points above, the right move is a clarifying email before countersigning, not a note in the deal memo flagging it post-close. Book a call with counsel, run the clause list, and counter in writing. That is what the analyst actually does on a Tuesday.